Oral fluid and plasma 3,4-methylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administration

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 12, 2013, Pages 4067-4076

  Desrosiers, Nathalie A ^a,b   Barnes, Allan J ^a   Hartman, Rebecca L ^a,b   Scheidweiler, Karl B ^a   Kolbrich Spargo, Erin A ^c   Gorelick, David A ^a   Goodwin, Robert S ^d   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c Southwest Institute of Forensic Science Dallas   (United States)

^d NONE   (United States)

Author keywords

3,4 Methylenedioxymethamphetamine; MDMA; Oral fluid; Toxicology

Indexed keywords

CHEMICAL ANALYSIS;

3 ,4-METHYLENEDIOXYMETHAMPHETAMINE; INTERSUBJECT VARIATION; MDMA; ORAL FLUIDS; PEAK CONCENTRATIONS; PLASMA CONCENTRATION; SAMPLE COLLECTION; TOXICOLOGY;

CHEMISTRY;

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; SALIVA; SUBSTANCE ABUSE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SALIVA; SUBSTANCE ABUSE DETECTION; YOUNG ADULT;

EID: 84886848201     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-6848-7     Document Type: Article

References (17)

1. UNODC (United Nations Office on Drugs and Crime) (2011) World Drug Report 2011. Vienna
2. Lacey JH, Kelley-Baker T, Furr-Holden D, Voas RB, Romano E, Ramirez A, Brainard K, Moore C, Torres P, Berning A (2009) 2007 National Roadside Survey of Alcohol and Drug Use by Drivers: Drug Results. National Highway Traffic Safety Administration Office of Behavioral Safety Research
3. Drummer OH, Kourtis I, Beyer J, Tayler P, Boorman M, Gerostamoulos D (2012) The prevalence of drugs in injured drivers. For Sci Int 215(1-3):14-17
4. Barnes AJ, Scheidweiler KB, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA (2011) MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration. Ther Drug Monit 33(5):602-608
5. Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, Huestis MA (2008) Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Ther Drug Monit 30(3):320-332
6. Samyn N, van Haeren C (2000) On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users. Int J Legal Med 113:150-154
7. Samyn N, De Boeck G, Wood M, Lamers CTJ, De Waard D, Brookhuis KA, Verstraete AG, Riedel WJ (2002) Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions. Fors Sci Int 128:90-97
8. Peters FT, Samyn N, Kraemer T, Riedel WJ, Maurer HH (2007) Negative-ion chemical ionization gas chromatography-mass spectrometry assay for enantioselective measurement of amphetamines in oral fluid: application to a controlled study with MDMA and driving under the influence cases. Clin Chem 53(4):702-710
9. Navarro M, Pichini S, Farre M, Ortuno J, Roset PN, Segura J, de La Torre R (2001) Usefulness of saliva for measurement of 3,4- methylenedioxymehamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH. Clin Chem 47:1788-1795
10. Kolbrich EA, Lowe RH, Huestis MA (2008) Two-dimensional gas chromatography/electron impact-mass spectrometry with cryofocusing for the sensitive, specific and simultaneous quantification of 3,4- methylenedioxymethamphetamine (MDMA, 3,4-methylenedioxyamphetamine (MDA), 4-hydroxy-3-methoxymethamphetamine (HMMA), 4-hydroxy-3-methoxyamphetamine (HMA), and 3,4-methylenedioxyethylamphetamine (MDEA) in human plasma. Clin Chem 54:379-387
11. Scheidweiler KB, Huestis MA (2006) A validated gas chromatographic- electron impact ionization mass spectrometric method for methylenedioxymethamphetamine (MDMA), methamphetamine and metabolites in oral fluid. J Chromatogr B 835:90-99
12. Walsh JM, Verstraete AG, Huestis MA, Morland J (2008) Guidelines for research on drugged driving. Addiction 103:1258-1268
13. Pil K, Raes E, Neste TVd, Verstraete A (2007) Toxicological analyses in the DRUID epidemiological studies: analytical methods, target analytes and analytical cut-offs. Paper presented at the European Integrated Project DRUID 2007
14. Bush DM (2008) The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations. For Sci Int 174(2-3):111-119
15. Garrett ER, Seyda K, Marroum P (1991) High performance liquid chromatographic assays of the illicit designer drug "ecstasy", a modified amphetamine, with applications to stability, partitioning and plasma protein binding. Acta Pharm Nord 3(1):9-14
16. Moffat AC, Osselton MD, Widdop B, Galichet LY (2004) Clarke's analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem material, 3rd edn. Pharmaceutical Press, London
17. Barfknecht CF, Nichols DE (1975) Correlation of psychotomimetic activity of phenethylamines and amphetamines with 1-octanol-water partition coefficients. J Med Chem 18(2):208-210